跳至主要内容
临床试验/NCT03459248
NCT03459248已完成不适用

Metoclopramide-Ondansetron Dual Therapy vs Metoclopramide Monotherapy for Treatment of Nausea and Vomiting Post Laparoscopic Cholecystectomy

Makassed General Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2018年2月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
postoperative nausea and vomiting

研究概览

简要总结

The incidence of postoperative nausea and vomiting (PONV) after general anesthesia is up to 30% when inhalational anesthetics are used with no prophylaxis. This makes PONV one of the most common complaints following surgery under general anesthesia, together with postoperative pain.

详细描述

This is a prospective, randomized, double-blind controlled clinical trial. Written informed consent will be obtained from patients. Patients will be randomly assigned using the sealed envelope technique into 2 equal groups:

Group 1: Patients will receive 10 mg metoclopramide with 4mg ondansetron before induction of general anesthesia.

Group 2: Patients will receive 10 mg metoclopramide before induction of general anesthesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aging 16 years and above
  • Patients undergoing laparoscopic cholecystectomy under General Anesthesia at Makassed General Hospital

排除标准

  • Patients with history of motion sickness
  • Patients on previous treatment by anti-emetics for dizziness, vertigo or other causes of nausea and vomiting
  • Patients with any type of allergy to metoclopramide or ondansetron
  • Patients refusing to be part of the study (refusal to sign consent)
  • Patients on previous treatment by opioids

研究组 & 干预措施

Dual therapy

Experimental

Patients will receive 10 mg metoclopramide with 4mg ondansetron before induction of general anesthesia

干预措施: Dual therapy (Other)

Dual therapy

Experimental

Patients will receive 10 mg metoclopramide with 4mg ondansetron before induction of general anesthesia

干预措施: General anesthesia (Other)

Monotherapy

Active Comparator

Patients will receive 10 mg metoclopramide before induction of general anesthesia.

干预措施: Monotherapy (Other)

Monotherapy

Active Comparator

Patients will receive 10 mg metoclopramide before induction of general anesthesia.

干预措施: General anesthesia (Other)

结局指标

主要结局

postoperative nausea and vomiting

时间窗: 36 hours postoperatively

The Primary aim of this study is to compare the effect of prophylactic combination therapy (dual therapy) metoclopramide-ondansetron vs. ondansetron monotherapy for the treatment of postoperative nausea and vomiting after laparoscopic cholecystectomy. This will be assessed through a questionnaire with yes or no question where yes indicates the presence of nausea or vomiting and no indicating the absence of nausea or vomiting.

次要结局

  • Surgeon satisfaction(36 hours postoperatively)
  • Patient satisfaction(36 hours postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zoher Naja

Chairperson of Anesthesia and Pain Management Department

Makassed General Hospital

研究点 (1)

Loading locations...

相似试验